Casein kinase 2 regulates vaccinia virus actin tail formation

Virology

Volumn 423, Issue 2, 2012, Pages 143-151

  Alvarez, Diego E ^a   Agaisse, Hervé ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Actin; Arp2 3; Casein kinase 2; Dissemination, spread from cell to cell; Listeria; N WASP; Phosphorylation; RNAi; Src; TBB; Vaccinia virus

Indexed keywords

ACTIN; CASEIN KINASE II; CASEIN KINASE II INHIBITOR; PROTEIN SERINE THREONINE KINASE INHIBITOR; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; POXVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEPLETION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VACCINIA VIRUS; VACCINIA VIRUS INFECTION; VIRUS CELL INTERACTION; VIRUS RECOMBINANT;

ACTINS; CASEIN KINASE II; CELL LINE; HUMANS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; VACCINIA; VACCINIA VIRUS;

LISTERIA; VACCINIA VIRUS;

EID: 84855789366     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.12.003     Document Type: Article

References (45)

1. Carter G.C., Rodger G., Murphy B.J., Law M., Krauss O., Hollinshead M., Smith G.L. Vaccinia virus cores are transported on microtubules. J. Gen. Virol. 2003, 84(Pt 9):2443-2458.
2. Chong R., Swiss R., Briones G., Stone K.L., Gulcicek E.E., Agaisse H. Regulatory mimicry in Listeria monocytogenes actin-based motility. Cell Host Microbe 2009, 6(3):268-278.
3. Damon I.K. Poxviruses. Fields Virology 2007, 2. 2 vols. Lippincott Williams & Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
4. Duncan J.S., Gyenis L., Lenehan J., Bretner M., Graves L.M., Haystead T.A., Litchfield D.W. An unbiased evaluation of CK2 inhibitors by chemoproteomics: characterization of inhibitor effects on CK2 and identification of novel inhibitor targets. Mol. Cell. Proteomics 2008, 7(6):1077-1088.
5. Earl P.L., Cooper N., Wyatt L.S., Moss B., Carroll M.W. Preparation of cell cultures and vaccinia virus stocks. Current Protocols in Molecular Biology 1998, 16.16.1-16.16.13. John Wiley & Sons, Inc.
6. Earl P.L., Moss B., Wyatt L.S., Carroll M.W. Generation of recombinant vaccinia viruses. Current Protocols in Molecular Biology 1998, 16.17.1-16.17.19. John Wiley Sons, Inc.
7. Engelstad M., Smith G.L. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology 1993, 194(2):627-637.
8. Engelstad M., Howard S.T., Smith G.L. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 1992, 188(2):801-810.
9. Falkner F.G., Moss B. Transient dominant selection of recombinant vaccinia viruses. J. Virol. 1990, 64(6):3108-3111.
10. Franck N., Le Seyec J., Guguen-Guillouzo C., Erdtmann L. Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome. J. Virol. 2005, 79(5):2700-2708.
11. Frischknecht F., Moreau V., Rottger S., Gonfloni S., Reckmann I., Superti-Furga G., Way M. Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling. Nature 1999, 401(6756):926-929.
12. Hiller G., Weber K. Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment. J. Virol. 1985, 55(3):651-659.
13. Hollinshead M., Rodger G., Van Eijl H., Law M., Hollinshead R., Vaux D.J., Smith G.L. Vaccinia virus utilizes microtubules for movement to the cell surface. J. Cell Biol. 2001, 154(2):389-402.
14. Hui E.K., Nayak D.P. Role of G protein and protein kinase signalling in influenza virus budding in MDCK cells. J. Gen. Virol. 2002, 83(Pt 12):3055-3066.
15. Katz E., Ward B.M., Weisberg A.S., Moss B. Mutations in the vaccinia virus A33R and B5R envelope proteins that enhance release of extracellular virions and eliminate formation of actin-containing microvilli without preventing tyrosine phosphorylation of the A36R protein. J. Virol. 2003, 77(22):12266-12275.
16. Law M., Hollinshead R., Smith G.L. Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread. J. Gen. Virol. 2002, 83(Pt 1):209-222.
17. Mathew E., Sanderson C.M., Hollinshead M., Smith G.L. The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation. J. Virol. 1998, 72(3):2429-2438.
18. Meggio F., Pinna L.A. One-thousand-and-one substrates of protein kinase CK2?. FASEB J. 2003, 17(3):349-368.
19. Miyata Y., Nishida E. CK2 controls multiple protein kinases by phosphorylating a kinase-targeting molecular chaperone, Cdc37. Mol. Cell. Biol. 2004, 24(9):4065-4074.
20. Modrof J., Lymperopoulos K., Roy P. Phosphorylation of bluetongue virus nonstructural protein 2 is essential for formation of viral inclusion bodies. J. Virol. 2005, 79(15):10023-10031.
21. Moreau V., Frischknecht F., Reckmann I., Vincentelli R., Rabut G., Stewart D., Way M. A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization. Nat. Cell Biol. 2000, 2(7):441-448.
22. Moss B. Poxviridae: The Viruses and Their Replication. Fields Virology 2007, 2. 2 vols. Lippincott Williams & Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
23. Newsome T.P., Scaplehorn N., Way M. SRC mediates a switch from microtubule- to actin-based motility of vaccinia virus. Science 2004, 306(5693):124-129.
24. Newsome T.P., Weisswange I., Frischknecht F., Way M. Abl collaborates with Src family kinases to stimulate actin-based motility of vaccinia virus. Cell. Microbiol. 2006, 8(2):233-241.
25. Reeves P.M., Bommarius B., Lebeis S., McNulty S., Christensen J., Swimm A., Chahroudi A., Chavan R., Feinberg M.B., Veach D., Bornmann W., Sherman M., Kalman D. Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases. Nat. Med. 2005, 11(7):731-739.
26. Reeves P.M., Smith S.K., Olson V.A., Thorne S.H., Bornmann W., Damon I.K., Kalman D. Variola and monkeypox viruses utilize conserved mechanisms of virion motility and release that depend on abl and SRC family tyrosine kinases. J. Virol. 2011, 85(1):21-31.
27. Rietdorf J., Ploubidou A., Reckmann I., Holmstrom A., Frischknecht F., Zettl M., Zimmermann T., Way M. Kinesin-dependent movement on microtubules precedes actin-based motility of vaccinia virus. Nat. Cell Biol. 2001, 3(11):992-1000.
28. Rimoin A.W., Kisalu N., Kebela-Ilunga B., Mukaba T., Wright L.L., Formenty P., Wolfe N.D., Shongo R.L., Tshioko F., Okitolonda E., Muyembe J.J., Ryder R.W., Meyer H. Endemic human monkeypox, Democratic Republic of Congo, 2001-2004. Emerg. Infect. Dis. 2007, 13(6):934-937.
29. Rimoin A.W., Mulembakani P.M., Johnston S.C., Lloyd Smith J.O., Kisalu N.K., Kinkela T.L., Blumberg S., Thomassen H.A., Pike B.L., Fair J.N., Wolfe N.D., Shongo R.L., Graham B.S., Formenty P., Okitolonda E., Hensley L.E., Meyer H., Wright L.L., Muyembe J.J. Major increase in human monkeypox incidence 30years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(37):16262-16267.
30. Rodger G., Smith G.L. Replacing the SCR domains of vaccinia virus protein B5R with EGFP causes a reduction in plaque size and actin tail formation but enveloped virions are still transported to the cell surface. J. Gen. Virol. 2002, 83(Pt 2):323-332.
31. Roper R.L., Wolffe E.J., Weisberg A., Moss B. The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus. J. Virol. 1998, 72(5):4192-4204.
32. Scaplehorn N., Holmstrom A., Moreau V., Frischknecht F., Reckmann I., Way M. Grb2 and Nck act cooperatively to promote actin-based motility of vaccinia virus. Curr. Biol. 2002, 12(9):740-745.
33. Schmelz M., Sodeik B., Ericsson M., Wolffe E.J., Shida H., Hiller G., Griffiths G. Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J. Virol. 1994, 68(1):130-147.
34. Shaner N.C., Campbell R.E., Steinbach P.A., Giepmans B.N., Palmer A.E., Tsien R.Y. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat. Biotechnol. 2004, 22(12):1567-1572.
35. Smith G.L., Law M. The exit of vaccinia virus from infected cells. Virus Res. 2004, 106(2):189-197.
36. Smith G.L., Vanderplasschen A., Law M. The formation and function of extracellular enveloped vaccinia virus. J. Gen. Virol. 2002, 83(Pt 12):2915-2931.
37. Van Eijl H., Hollinshead M., Rodger G., Zhang W.H., Smith G.L. The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface. J. Gen. Virol. 2002, 83(Pt 1):195-207.
38. Ward B.M., Moss B. Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails. J. Virol. 2001, 75(23):11651-11663.
39. Ward B.M., Moss B. Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera. J. Virol. 2001, 75(10):4802-4813.
40. Ward B.M., Weisberg A.S., Moss B. Mapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteins. J. Virol. 2003, 77(7):4113-4126.
41. Weisswange I., Newsome T.P., Schleich S., Way M. The rate of N-WASP exchange limits the extent of ARP2/3-complex-dependent actin-based motility. Nature 2009, 458(7234):87-91.
42. Wolffe E.J., Isaacs S.N., Moss B. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. J. Virol. 1993, 67(8):4732-4741.
43. Wolffe E.J., Weisberg A.S., Moss B. Role for the vaccinia virus A36R outer envelope protein in the formation of virus-tipped actin-containing microvilli and cell-to-cell virus spread. Virology 1998, 244(1):20-26.
44. Wolffe E.J., Weisberg A.S., Moss B. The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein. J. Virol. 2001, 75(1):303-310.
45. Yi M., Ma Y., Yates J., Lemon S.M. Trans-complementation of an NS2 defect in a late step in hepatitis C virus (HCV) particle assembly and maturation. PLoS Pathog. 2009, 5(5):e1000403.